Lack of Association of Tegaserod With Adverse Cardiovascular Outcomes in a Matched Case-Control Study
Anderson et al.
J CARDIOVASC PHARMACOL THER 2009;14:170-175.
ABSTRACT
Olanzapine prolongs cardiac repolarization by blocking the rapid component of the delayed rectifier potassium current
Morissette et al.
J Psychopharmacol 2007;21:735-741.
ABSTRACT
Increase in Mortality Rate Following Coprescription of Cisapride and Contraindicated Drugs
Choi et al.
The Annals of Pharmacotherapy 2007;41:667-673.
ABSTRACT
| FULL TEXT
Comparative Evaluation of HERG Currents and QT Intervals following Challenge with Suspected Torsadogenic and Nontorsadogenic Drugs
Katchman et al.
J. Pharmacol. Exp. Ther. 2006;316:1098-1106.
ABSTRACT
| FULL TEXT
Spontaneous Adverse Event Reports of Serious Ventricular Arrhythmias, QT Prolongation, Syncope, and Sudden Death in Patients Treated with Cisapride
Barbey et al.
J CARDIOVASC PHARMACOL THER 2002;7:65-76.
ABSTRACT
Antidepressant Drug Interactions
Botts and Alfaro
Journal of Pharmacy Practice 2001;14:467-477.
ABSTRACT
Effects of cisapride on gall bladder emptying, intestinal transit, and serum deoxycholate: a prospective, randomised, double blind, placebo controlled trial
Veysey et al.
Gut 2001;49:828-834.
ABSTRACT
| FULL TEXT
In Vitro Metabolism of Tegaserod in Human Liver and Intestine: Assessment of Drug Interactions
Vickers et al.
Drug Metab. Dispos. 2001;29:1269-1276.
ABSTRACT
| FULL TEXT
Cisapride Associated With QTc Prolongation in Very Low Birth Weight Preterm Infants
Dubin et al.
Pediatrics 2001;107:1313-1316.
ABSTRACT
| FULL TEXT
Effects of Cisapride on Corrected QT Interval, Heart Rate, and Rhythm in Infants Undergoing Polysomnography
Benatar et al.
Pediatrics 2000;106:85e-85.
ABSTRACT
| FULL TEXT
Domperidone Should Not Be Considered a No-Risk Alternative to Cisapride in the Treatment of Gastrointestinal Motility Disorders
Drolet et al.
Circulation 2000;102:1883-1885.
ABSTRACT
| FULL TEXT
Interaction of Cisapride with the Human Cytochrome P450 System: Metabolism and Inhibition Studies
Desta et al.
Drug Metab. Dispos. 2000;28:789-800.
ABSTRACT
| FULL TEXT
Effect of Cisapride on the QT Interval in Infants With Gastroesophageal Reflux
Khoshoo et al.
Pediatrics 2000;105:24e-24.
ABSTRACT
| FULL TEXT
Cisapride and Proarrhythmia in Childhood
Benatar et al.
Pediatrics 1999;103:856-856.
FULL TEXT
Cisapride: A Survey of the Frequency of Use and Adverse Events in Premature Newborns
Ward et al.
Pediatrics 1999;103:469-472.
ABSTRACT
| FULL TEXT
Proarrhythmia Associated With Cisapride in Children
Hill et al.
Pediatrics 1998;101:1053-1056.
ABSTRACT
| FULL TEXT
Block of the Rapid Component of the Delayed Rectifier Potassium Current by the Prokinetic Agent Cisapride Underlies Drug-Related Lengthening of the QT Interval
Drolet et al.
Circulation 1998;97:204-210.
ABSTRACT
| FULL TEXT
Blockage of the HERG human cardiac K+ channel by the gastrointestinal prokinetic agent cisapride
Mohammad et al.
Am. J. Physiol. Heart Circ. Physiol. 1997;273:H2534-H2538.
ABSTRACT
| FULL TEXT
Effects of cisapride on QTc interval in neonates
Bernardini et al.
Arch. Dis. Child. Fetal Neonatal Ed. 1997;77:241F-243.
ABSTRACT
| FULL TEXT
Electrophysiological Characterization of the Prokinetic Agents Cisapride and Mosapride in Vivo and in Vitro: Implications for Proarrhythmic Potential?
Carlsson et al.
J. Pharmacol. Exp. Ther. 1997;282:220-227.
ABSTRACT
| FULL TEXT
Cisapride and Fatal Arrhythmia
Wysowski and Bacsanyi
NEJM 1996;335:290-291.
FULL TEXT
